AusPAR: Rituximab
Australian Public Assessment Report
Device/Product Name
Truxima, Ritemvia
Active ingredients
Rituximab
AusPAR Date
Published
Submission Number
PM-2017-00695-1-3
Submission Type
Extension of indication and major variation (new strength)
Decision
Approved